Zofran suit - Plantiffs request foreign regulatory files
Plaintiffs in Zofran Suit Request Foreign Regulatory Files
August 1, 2017
Several plaintiffs who are suing GlaxoSmithKline (GSK) over the alleged links between its anti-nausea drug Zofran and birth defects have requested that the judge in the case force the company to produce foreign regulatory files concerning the drug.
The plaintiffs contend that British, Canadian, and Japanese Zofran regulatory documentation may produce evidence that GSK did not reveal to American regulators the potential for Zofran to cause birth defects when it is used by pregnant women.
Zofran has been the subject of numerous clinical studies and trials for its alleged links to birth defects. At issue are not just the drug’s alleged side effects, but whether GlaxoSmithKline knowingly concealed information about the alleged side effects from the U.S. Food and Drug Administration (FDA).
The Multi-District Litigation (MDL) case is ongoing in federal court in Boston.
If you took Zofran while pregnant, and your child was born with birth defects, you may have a case. Contact the attorneys at TheLawFirm.com immediately.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!